MedPath

Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients

Phase 3
Terminated
Conditions
TB
Interventions
Registration Number
NCT01055145
Lead Sponsor
Seoul National University Hospital
Brief Summary

Fluoroquinolone is a one of the most important drugs for treatment of multidrug-resistant TB (MDR-TB). Among them, levofloxacin and moxifloxacin has been used most widely. However, there is no study to directly compare the efficacy of levofloxacin and moxifloxacin among MDR-TB patients. The investigators will compare the efficacy of levofloxacin and moxifloxacin through a prospective multicenter randomized open label phase III trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
182
Inclusion Criteria
  • Patients with multidrug-resistant TB, but sensitive to levofloxacin and moxifloxacin
Exclusion Criteria
  • Achieved negative conversion of M. TB culture before the enrollment
  • Positive anti-HIV antibody
  • Pregnant women or sexually active women without using proper birth control method
  • Serum creatine grater than 2mg/dL, or urine protein greater than 2+
  • Serum total bilirubin greater than 2 mg/dL or AST and ALT greater than 1.5 times of normal upper limit
  • History or current arrhythmia
  • Hypersensitivity to levofloxacin, moxifloxacin,or rifabutin
  • Should use drug containing metal-ion, warfarin, phenytoin, theophylline, probenecid regularly

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
moxifloxacinlevofloxacin, moxifloxacinMoxifloxacin 400mg po per day for 3 months
levofloxacinlevofloxacin, moxifloxacinLevofloxacin 750mg po per day for 3 months
Primary Outcome Measures
NameTimeMethod
Negative conversion of M. tuberculosis3 months after initiation of treatment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (29)

Daegu Catholic University Medical Center

🇰🇷

Daegu, Korea, Republic of

Inje University Pusan Paik Hospital

🇰🇷

Pusan, Korea, Republic of

Severance Hospital

🇰🇷

Seoul, Korea, Republic of

Kangwon National University Hospital

🇰🇷

Chuncheon, Korea, Republic of

Chungbuk National University Hospital

🇰🇷

Cheongju, Chungbuk, Korea, Republic of

Bundang CHA Hospital

🇰🇷

Bundang, Gyeonggi, Korea, Republic of

Catholic University of Korea Bucheon St. Mary's Hospital

🇰🇷

Bucheon, Gyeonggi, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Bundang, Gyeonggi, Korea, Republic of

Korea University Ansan Hospital

🇰🇷

Ansan, Gyeonggi, Korea, Republic of

Hallym University Sacred Heart Hospital

🇰🇷

Pyeongchon, Gyeonggi, Korea, Republic of

Gyeongsang National University Hospital

🇰🇷

Jinju, Korea, Republic of

Gachon University Gil Hospital

🇰🇷

Incheon, Korea, Republic of

Keimyung University Dongsan Medical Center

🇰🇷

Daegu, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Ewha Womans University Mokdong Hospital

🇰🇷

Seoul, Korea, Republic of

Inje University Sanggye Paik Hospital

🇰🇷

Seoul, Korea, Republic of

Kangbuk Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Korea University Guro Hospital

🇰🇷

Seoul, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Korean Institute of Tuberculosis

🇰🇷

Seoul, Korea, Republic of

Chung-Ang University Yong-san Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Boramae Medical Center

🇰🇷

Seoul, Korea, Republic of

East-West Neo Medical Center

🇰🇷

Seoul, Korea, Republic of

Korea University Anam Hospital

🇰🇷

Seoul, Korea, Republic of

Chonnam National University Hospital

🇰🇷

Gwangju, Korea, Republic of

Masan Samsung Medical Center

🇰🇷

Masan, Korea, Republic of

Pusan National University Hospital

🇰🇷

Pusan, Korea, Republic of

Seoul Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath